AstraZeneca

AstraZeneca, Oxford University Say Their COVID-19 Vaccine Has Average 70% Efficacy

One dosing regimen was shown to have 90% efficacy and another showed 62% efficacy.
By 

AstraZeneca COVID-19 Vaccine Data Shows Promise In Elderly

Researchers said they expect to release their late-stage trial results by Christmas. This would follow rival drugmakers releasing theirs earlier this month.
By Kate Kelland, Alistair Smout, Reuters

Fauci Calls AstraZeneca Vaccine Pause Unfortunate But Not Uncommon

The U.S. infectious disease expert said he hoped the pharmaceutical company could proceed with its trial.
By Reuters

AstraZeneca Puts Hold On Potential COVID-19 Vaccine After ‘Potentially Unexplained Illness’

The company stressed that such actions were routine in clinical trials and said an independent team would review safety data.
By 

Why Poor Countries Could Be Priced Out Of A Covid-19 Vaccine

Pharma giant AstraZeneca says it's "too early to comment on pricing post-pandemic".
By 
FROM HUFFPOST U.K.

AstraZeneca Could Price Poor Out Of COVID Vaccine After Pandemic, Warns Trial Volunteer

The pharma giant said it was "too early to comment on pricing post-pandemic" for the coronavirus drug it is trialing at Oxford University.
By 

UK To Get 30m Coronavirus Vaccine Doses By September If Oxford Trials Succeed

Business secretary Alok Sharma hails deal between AstraZeneca and Oxford University to manufacture vaccine.
By 
FROM HUFFPOST U.K.